Arrhythmia monitoring and outcome after myocardial infarction (BIO|GUARD-MI): a randomized trial.

ABSTRACT:

Objectives

Cardiac arrhythmias predict poor outcome after myocardial infarction (MI). We studied if arrhythmia monitoring with an insertable cardiac monitor (ICM) can improve treatment and outcome.

Design

BIO|GUARD-MI was a randomized, international open-label study with blinded outcome assessment.

Setting

Tertiary care facilities monitored the arrhythmias, while the follow-up remained with primary care physicians.

Participants

Patients after ST-elevation (STEMI) or non-ST-elevation MI with an ejection fraction >35% and a CHA₂DS₂-VASc score ≥4 (men) or ≥5 (women).

Interventions

Patients were randomly assigned to receive or not receive an ICM in addition to standard post-MI treatment. Device-detected arrhythmias triggered immediate g

SUBMITTER: Jons C 

PROVIDER: S-EPMC11132184 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature